FDA Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works,

Recognizing that clinical trials of the drug had provided incomplete … on the condition that the manufacturer, Biogen, conduct a new clinical trial., Recognizing that clinical trials of the drug had provided incomplete … on the condition that the manufacturer, Biogen, conduct a new clinical trial., Read More

Scroll to Top